37 results
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:17pm
, to applicable federal and state anti-kickback, fraud and abuse, false claims, transparency, health information privacy and security, and other healthcare laws … fraud and abuse and other healthcare laws and regulations, including the federal Anti-Kickback Statute and the federal False Claims Act, that may
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:11pm
will be subject, directly or indirectly, to applicable federal and state anti-kickback, fraud and abuse, false claims, transparency, health information … entities may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations, including the federal Anti-Kickback Statute
D
a79os6476g
3 Jan 24
$50.00 mm in equity / options / securities to be acquired, sold $50.00 mm, 2 investors
4:32pm
8-K
EX-10.1
0vxkk831htltrs32xvz
26 Dec 23
Zymeworks Announces $50 Million Private Placement to EcoR1 Capital
8:09am
8-K
EX-10.2
kbvmoyru 3d6w
26 Dec 23
Zymeworks Announces $50 Million Private Placement to EcoR1 Capital
8:09am
8-K
EX-10.1
mlohodho
16 May 23
Entry into a Material Definitive Agreement
8:30am